{"id":6653,"date":"2024-11-21T14:09:58","date_gmt":"2024-11-21T13:09:58","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=publication&p=6653"},"modified":"2025-04-28T21:44:48","modified_gmt":"2025-04-28T19:44:48","slug":"sonrotoclax-overcomes-bcl2-g101v-mutation-induced-venetoclax-resistance-in-preclinical-models-of-hematologic-malignancy","status":"publish","type":"publication","link":"https:\/\/beonemedaffairs.com\/us\/publication\/sonrotoclax-overcomes-bcl2-g101v-mutation-induced-venetoclax-resistance-in-preclinical-models-of-hematologic-malignancy\/","title":{"rendered":"Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy\u00a0"},"content":{"rendered":"","protected":false},"template":"","post-tag":[],"class_list":["post-6653","publication","type-publication","status-publish","hentry","disease_state-hematologic-malignancies","molecule-sonrotoclax"],"acf":[],"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication\/6653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=6653"}],"wp:term":[{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=6653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}